Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase 3 trial of dovitinib vs sorafenib in patients with metastatic renal cell carcinoma after 1 prior VEGF pathway-targeted and 1 prior mTOR inhibitor therapy

EUROPEAN JOURNAL OF CANCER(2013)

Cited 29|Views23
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined